177 related articles for article (PubMed ID: 29081351)
1. Integrating biological treatment mechanisms into randomized clinical trials: Design of PROGrESS (PROlonGed ExpoSure and Sertraline Trial).
Rauch SAM; Simon NM; Kim HM; Acierno R; King AP; Norman SB; Venners MR; Porter K; Phan KL; Tuerk PW; Allard C; Liberzon I; Rothbaum BO; Martis B; Stein MB; Hoge CW
Contemp Clin Trials; 2018 Jan; 64():128-138. PubMed ID: 29081351
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Prolonged Exposure Therapy, Sertraline Hydrochloride, and Their Combination Among Combat Veterans With Posttraumatic Stress Disorder: A Randomized Clinical Trial.
Rauch SAM; Kim HM; Powell C; Tuerk PW; Simon NM; Acierno R; Allard CB; Norman SB; Venners MR; Rothbaum BO; Stein MB; Porter K; Martis B; King AP; Liberzon I; Phan KL; Hoge CW
JAMA Psychiatry; 2019 Feb; 76(2):117-126. PubMed ID: 30516797
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Response to Prolonged Exposure, Sertraline, and Their Combination for the Treatment of Military PTSD.
Rauch SAM; Kim HM; Lederman S; Sullivan G; Acierno R; Tuerk PW; Simon NM; Venners MR; Norman SB; Allard CB; Porter KE; Martis B; Bui E; Baker AW;
J Clin Psychiatry; 2021 Jun; 82(4):. PubMed ID: 34133087
[No Abstract] [Full Text] [Related]
4. Cortisol awakening response in PTSD treatment: Predictor or mechanism of change.
Rauch SAM; King A; Kim HM; Powell C; Rajaram N; Venners M; Simon NM; Hamner M; Liberzon I
Psychoneuroendocrinology; 2020 Aug; 118():104714. PubMed ID: 32446108
[TBL] [Abstract][Full Text] [Related]
5. Change in posttraumatic stress disorder-related thoughts during treatment: Do thoughts drive change when pills are involved?
Rauch SAM; Kim HM; Venners MR; Porter KE; Norman SB; Simon NM; Rothbaum BO; Tuerk PW; Acierno RE; Bui E; Powell C; Smith ER; Goetter E; McSweeney LB
J Trauma Stress; 2022 Apr; 35(2):496-507. PubMed ID: 34973039
[TBL] [Abstract][Full Text] [Related]
6. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome.
Yehuda R; Bierer LM; Pratchett LC; Lehrner A; Koch EC; Van Manen JA; Flory JD; Makotkine I; Hildebrandt T
Psychoneuroendocrinology; 2015 Jan; 51():589-97. PubMed ID: 25212409
[TBL] [Abstract][Full Text] [Related]
7. Residual symptoms of PTSD following Sertraline plus enhanced medication management, Sertraline plus PE, and PE plus placebo.
Tripp JC; Norman SB; Kim HM; Venners MR; Martis B; Simon NM; Stein MB; Allard CB; Rauch SAM;
Psychiatry Res; 2020 Sep; 291():113279. PubMed ID: 32763541
[TBL] [Abstract][Full Text] [Related]
8. Reductions in guilt cognitions following prolonged exposure and/or sertraline predict subsequent improvements in PTSD and depression.
Allard CB; Norman SB; Straus E; Kim HM; Stein MB; Simon NM; Rauch SAM;
J Behav Ther Exp Psychiatry; 2021 Dec; 73():101666. PubMed ID: 34147766
[TBL] [Abstract][Full Text] [Related]
9. Group-delivered cognitive/exposure therapy for PTSD in women veterans: A randomized controlled trial.
Castillo DT; Chee CL; Nason E; Keller J; C'de Baca J; Qualls C; Fallon SK; Haaland KY; Miller MW; Keane TM
Psychol Trauma; 2016 May; 8(3):404-412. PubMed ID: 26854355
[TBL] [Abstract][Full Text] [Related]
10. Augmenting Prolonged Exposure therapy for PTSD with intranasal oxytocin: A randomized, placebo-controlled pilot trial.
Flanagan JC; Sippel LM; Wahlquist A; Moran-Santa Maria MM; Back SE
J Psychiatr Res; 2018 Mar; 98():64-69. PubMed ID: 29294429
[TBL] [Abstract][Full Text] [Related]
11. Exposure Therapy and Simultaneous Repetitive Transcranial Magnetic Stimulation: A Controlled Pilot Trial for the Treatment of Posttraumatic Stress Disorder.
Fryml LD; Pelic CG; Acierno R; Tuerk P; Yoder M; Borckardt JJ; Juneja N; Schmidt M; Beaver KL; George MS
J ECT; 2019 Mar; 35(1):53-60. PubMed ID: 29952863
[TBL] [Abstract][Full Text] [Related]
12. Sudden gains in prolonged exposure and sertraline for chronic PTSD.
Jun JJ; Zoellner LA; Feeny NC
Depress Anxiety; 2013 Jul; 30(7):607-13. PubMed ID: 23633445
[TBL] [Abstract][Full Text] [Related]
13. Predictors of completion of exposure therapy in OEF/OIF veterans with posttraumatic stress disorder.
Gros DF; Price M; Yuen EK; Acierno R
Depress Anxiety; 2013 Nov; 30(11):1107-13. PubMed ID: 24151141
[TBL] [Abstract][Full Text] [Related]
14. Design of VA Cooperative Study #591: CERV-PTSD, comparative effectiveness research in veterans with PTSD.
Schnurr PP; Chard KM; Ruzek JI; Chow BK; Shih MC; Resick PA; Foa EB; Marx BP; Huang GD; Lu Y
Contemp Clin Trials; 2015 Mar; 41():75-84. PubMed ID: 25457792
[TBL] [Abstract][Full Text] [Related]
15. The influence of posttraumatic stress disorder treatment on anxiety sensitivity: Impact of prolonged exposure, sertraline, and their combination.
Luciano MT; Norman SB; Allard CB; Acierno R; Simon NM; Szuhany KL; Baker AW; Stein MB; Martis B; Tuerk PW; Rauch SAM;
J Trauma Stress; 2023 Feb; 36(1):157-166. PubMed ID: 36451271
[TBL] [Abstract][Full Text] [Related]
16. An examination of the roles of trauma exposure and posttraumatic stress disorder on emotion regulation strategies of Operation Iraqi Freedom, Operation Enduring Freedom, and Operation New Dawn veterans.
Sippel LM; Roy AM; Southwick SM; Fichtenholtz HM
Cogn Behav Ther; 2016 Sep; 45(5):339-50. PubMed ID: 27195939
[TBL] [Abstract][Full Text] [Related]
17. Enhancing exposure therapy for PTSD with yohimbine HCL: protocol for a double-blind, randomized controlled study implementing subjective and objective measures of treatment outcome.
Wangelin BC; Powers MB; Smits JA; Tuerk PW
Contemp Clin Trials; 2013 Nov; 36(2):319-26. PubMed ID: 23939512
[TBL] [Abstract][Full Text] [Related]
18. The impact of PTSD treatment on the cortisol awakening response.
Pacella ML; Feeny N; Zoellner L; Delahanty DL
Depress Anxiety; 2014 Oct; 31(10):862-9. PubMed ID: 25327949
[TBL] [Abstract][Full Text] [Related]
19. Doubly Randomized Preference Trial of Prolonged Exposure Versus Sertraline for Treatment of PTSD.
Zoellner LA; Roy-Byrne PP; Mavissakalian M; Feeny NC
Am J Psychiatry; 2019 Apr; 176(4):287-296. PubMed ID: 30336702
[TBL] [Abstract][Full Text] [Related]
20. Prolonged exposure vs eye movement desensitization and reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial.
van den Berg DP; de Bont PA; van der Vleugel BM; de Roos C; de Jongh A; Van Minnen A; van der Gaag M
JAMA Psychiatry; 2015 Mar; 72(3):259-67. PubMed ID: 25607833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
